Evidence map›Paper›PMID 31030484›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2019

Effect of DNA Methyltransferase in Comparison to and in Combination with Histone Deacetylase Inhibitors on Hepatocellular Carcinoma HepG2 Cell Line

Masumeh Sanaei, Fraidoon Kavoosi

Open access · goldAbstract readComparative Study
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Masumeh SanaeiResearch Center for Non-Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran. Email: Kavoosifraidoon@gmail.com
Fraidoon KavoosiResearch Center for Non-Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran. Email: Kavoosifraidoon@gmail.com
Jahrom University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: DNA demethylating agents and histone deacetylase inhibitors can affect reactivation of gene expression and apoptosis induction by DNA acetylation and demethylation. The aim of the present study was to analyze the effects of DNA demethylating agent genistein (GE) and histone deacetylase inhibitor valproic acid VPA), alone and combined, on hepatocellular carcinoma Hep G2 cell line. Methods: The cells were treated with various doses of genistein and valproic acid (alone and combined) and the MTT assay and flow cytometry were used to determine cell viability and apoptosis. Results: Genistein and valproic acid inhibited the growth of HepG 2 cells significantly. Result of flow cytometry demonstrated that genistein and valproic acid (alone and combined) induce apoptosis significantly in a time‑dependent manner. Conclusions: Genistein and valproic acid can significantly inhibit proliferation and induce apoptosis in HepG2 cell line. The apoptotic effects of GE in combination with VPA were more significant that of each compound alone.

Indexed as

Anticarcinogenic AgentsApoptosisCarcinoma, HepatocellularCell ProliferationDNA Modification MethylasesDrug CombinationsDrug SynergismEnzyme InhibitorsGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticGenisteinHep G2 CellsHistone Deacetylase InhibitorsHumansLiver NeoplasmsValproic AcidAnticarcinogenic AgentsDNA Modification MethylasesDrug CombinationsEnzyme InhibitorsGenisteinHistone Deacetylase InhibitorsValproic AcidapoptosisGenisteinhepatocellular carcinomaproliferationvalproic acid

Identifiers

PMID31030484
PMCPMC6948907
OpenAlexW2912391396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.